Semaglutide and tirzepatide linked to fewer alcohol-related hospital visits
View as a Web Page
News Medical
 
  Diabetes Diabetes logo  
  The latest diabetes news from News Medical  
 Evidence shows artificial sweeteners cannot be judged as a single groupEvidence shows artificial sweeteners cannot be judged as a single group
 
This narrative review found that non-nutritive artificial sweeteners have compound-specific and context-dependent associations with gut microbiota, metabolism, and health-related outcomes. Evidence does not support treating all sweeteners as uniformly harmful or safe, with human findings often limited or inconsistent.
 
 
 Semaglutide and tirzepatide linked to fewer alcohol-related hospital visitsSemaglutide and tirzepatide linked to fewer alcohol-related hospital visits
 
Newer GLP-1 receptor agonists, including semaglutide and tirzepatide, were associated with fewer alcohol-related ED visits or hospitalizations among adults with alcohol use disorder and type 2 diabetes or obesity.
 
   Cambridge scientists solve brain puzzle behind popular obesity drugsCambridge scientists solve brain puzzle behind popular obesity drugs
 
Cambridge scientists have solved the mystery of why both stimulating and blocking a particular 'switch' in the brain can help people lose weight – findings which could help boost the effectiveness of obesity drugs.
 
   Handheld breathalyzer enables precise monitoring of fat metabolismHandheld breathalyzer enables precise monitoring of fat metabolism
 
Researchers from ETH Zurich have developed a portable measuring device that detects the metabolic marker acetone in breath almost as accurately as a mass spectrometer.
 
   Novel bioinspired dressing uses body force to heal woundsNovel bioinspired dressing uses body force to heal wounds
 
A bioinspired material, developed by scientists at Imperial College London, accelerates wound healing and the repair of human skin.
 
 Study reveals how gum disease drives systemic inflammation
 
A recent study revealed that periodontitis reprograms bone marrow neutrophils through a Chac2-driven glutathione metabolic pathway, promoting a highly inflammatory N1 state that fuels systemic inflammation.
 
 
 Smart ring continuously tracks multiple health biomarkers from finger sweat
 
Smart ring continuously tracks multiple health biomarkers from finger sweatEngineers at the University of California San Diego created a smart ring that simultaneously and continuously monitors up to four different chemical biomarkers from finger sweat.
 
 
 Prototype smart ring tracks multiple sweat biomarkers
 
Prototype smart ring tracks multiple sweat biomarkersThe CHARM smart ring enables continuous monitoring of biochemical markers in sweat, paving the way for advanced metabolic health tracking and diabetes support.
 
 
 Red meat intake emerges as a potential pancreatic cancer risk factor
 
Red meat intake emerges as a potential pancreatic cancer risk factorA systematic review and meta-analysis of 16 studies involving nearly 2 million participants found that higher red meat intake was associated with a modestly higher risk of pancreatic cancer. Processed meat intake showed no statistically significant association, although variation between studies means a small effect cannot be excluded.
 
 
 Nutritional quality matters more than processing level for long-term health
 
Nutritional quality matters more than processing level for long-term healthWhat makes a diet healthy-or not? According to a new study, nutritional quality matters more than processing level when it comes to long-term health.
 
 
 Taste preference genes drive overeating and metabolic disease risk
 
Taste preference genes drive overeating and metabolic disease riskEver wonder why some people crave sweets while others can take them or leave them? Preliminary findings from a new study suggest that people who carry certain genetic variants associated with a preference for sweet or fatty tastes not only tend to eat more of these foods but also have a higher risk of obesity and type 2 diabetes as a result.
 
 
 GLP-1 receptor agonists may increase hair loss risk
 
GLP-1 receptor agonists may increase hair loss riskUse of glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity are associated with an increased risk of hair loss (alopecia) in adults with type 2 diabetes, finds a study published by The BMJ today.
 
 
 Higher neuroticism may curb strenuous exercise, genetic analysis suggests
 
Higher neuroticism may curb strenuous exercise, genetic analysis suggestsResearchers used a UK survey and genetic data to examine whether higher neuroticism is associated with lower exercise engagement. Under the study’s Mendelian randomization assumptions, higher neuroticism was estimated to reduce participation in moderate and vigorous physical activity, while conscientiousness may lessen this effect.
 
 
 Photo-based calorie-tracking apps fall short in estimating meal nutrition
 
Photo-based calorie-tracking apps fall short in estimating meal nutritionThanks to advances in AI, popular calorie-tracking apps can now use a photo of a meal to estimate the nutritional content of what you're eating.
 
 
 Modifiable cardiovascular risk factors linked to unstable coronary artery plaques
 
Modifiable cardiovascular risk factors linked to unstable coronary artery plaquesCardiovascular risk factors are linked to higher risk of heart disease, but it has been unknown how they are related to abrupt closure of the coronary arteries leading to heart attack and sudden cardiac death.
 
 
 Endotrophin may reveal metabolic risks linked to changing body fat
 
Endotrophin may reveal metabolic risks linked to changing body fatResearchers have identified a biological marker that rises and falls as body fat changes, offering new insight into how weight gain and weight loss may influence metabolic health.
 
 
 Emerging PPAR therapies offer new hope for primary biliary cholangitis
 
Emerging PPAR therapies offer new hope for primary biliary cholangitisPrimary biliary cholangitis is a rare autoimmune disease that affects the liver and can progress to cirrhosis. It occurs when the immune system attacks the small bile ducts within the liver. As a result, bile builds up, leading to inflammation and progressive liver damage. Although a first-line treatment exists, 40% of patients do not respond adequately to it or cannot tolerate it, so new treatment options need to be developed.
 
 
 New study reveals massive gap in American blood pressure care
 
New study reveals massive gap in American blood pressure careNearly 23 million Americans with blood pressure 130/80 mm Hg or higher may be eligible for blood-pressure-lowering medications based on the 2025 American Heart Association/American College of Cardiology guideline, according to new, independent research published today in the Journal of the American Heart Association, an open access, peer-reviewed scientific journal of the American Heart Association.
 
 
 Urbanization reshapes gut microbiomes across diverse South Asian communities
 
Urbanization reshapes gut microbiomes across diverse South Asian communitiesUrbanization is one of the most consequential demographic shifts of the 21st century. As communities move from traditional or rural to urbanized ways of life, changes in diet, lifestyle, and environmental exposures can influence many aspects of human biology and health.
 
 
 Primary care practices successfully deliver family-based childhood obesity treatment
 
Primary care practices successfully deliver family-based childhood obesity treatmentChildhood obesity affects one in five children in the U.S., yet most families have limited access to specialized weight-management programs for children.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026